 |
|
Results of Repeat Sigmoidoscopy 3 Years After a Negative Examination
Robert E. Schoen, MD, MPH;
Paul F. Pinsky, PhD;
Joel L. Weissfeld, MD, MPH;
Robert S. Bresalier, MD;
Timothy Church, PhD;
Philip Prorok, PhD;
John K. Gohagan, PhD; for the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group
JAMA. 2003;290:41-48.
Context The necessary frequency of endoscopic colorectal cancer screening after a negative examination is uncertain.
Objective To examine the yield of adenomas and cancer in the distal colon found by repeat flexible sigmoidoscopy (FSG) 3 years after a negative examination.
Design, Setting, and Participants Participants were drawn from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO), a randomized, controlled community-based study of cancer screening. The mean (SD) age was 65.7 (4.0) years at study entry (1993-1995) and 61.6% were men. Individuals underwent screening FSG at baseline and at 3 years as part of the protocol and were referred to their personal physicians for further evaluation of screen-detected abnormalities. Results from subsequent diagnostic evaluations were tracked in a standardized fashion. Of 11 583 eligible for repeat screening FSG 3 years after an initial negative examination, 9317 (80.4%) returned.
Main Outcome Measures Polyp or mass detection in distal colon at year 3 repeat FSG; incidence of adenoma or cancer in distal colon at year 3 examination; determination of reason for detection (increased depth of insertion or improved preparation at the year 3 examination or detection in a previously examined area).
Results A total of 1292 returning participants (13.9%) had a polyp or mass detected by FSG 3 years after the initial examination. In the distal colon, 3.1% (292/9317) were found to have an adenoma or cancer. The incidence of advanced adenoma (n = 72) or cancer (n = 6) in the distal colon was 78 (0.8%) of 9317. Of individuals with advanced distal adenomas detected at the year 3 examination, 80.6% (58/72) had lesions found in a portion of the colon that had been adequately examined at the initial sigmoidoscopy.
Conclusions Repeat FSG 3 years after a negative examination will detect advanced adenomas and distal colon cancer. Although the overall percentage with detected abnormalities is modest, these data raise concern about the impact of a prolonged screening interval after a negative examination.
Author Affiliations: Departments of Medicine and Epidemiology and the University of Pittsburgh Cancer Institute, University of Pittsburgh, Pittsburgh, Pa (Drs Schoen and Weissfeld); Division of Cancer Prevention, National Cancer Institute, Bethesda, Md (Drs Pinsky, Prorok, and Gohagan); Division of Gastrointestinal Medicine and Nutrition, M. D. Anderson Cancer Center, Houston, Tex (Dr Bresalier); and Division of Environmental and Occupational Health, University of Minnesota, Minneapolis (Dr Church).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati
What's this?
RELATED LETTERS
Optimal Intervals and Techniques for Screening Sigmoidoscopy
Amnon Sonnenberg and David Lieberman
JAMA. 2003;290(16):2122-2123.
EXTRACT
| FULL TEXT
Optimal Intervals and Techniques for Screening Sigmoidoscopy
Richard C. Wender
JAMA. 2003;290(16):2123.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Screening Sigmoidoscopy— How Often and How Good?
Robert H. Fletcher
JAMA. 2003;290(1):106-108.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force
Whitlock et al.
ANN INTERN MED 2008;149:638-658.
ABSTRACT
| FULL TEXT
Five-Year Risk of Colorectal Neoplasia after Negative Screening Colonoscopy
Imperiale et al.
NEJM 2008;359:1218-1224.
ABSTRACT
| FULL TEXT
Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
Levin et al.
CA Cancer J Clin 2008;58:130-160.
ABSTRACT
| FULL TEXT
Screening for Colorectal Neoplasms With New Fecal Occult Blood Tests: Update on Performance Characteristics
Allison et al.
JNCI J Natl Cancer Inst 2007;99:1462-1470.
ABSTRACT
| FULL TEXT
Colorectal screening after polypectomy: a national survey study of primary care physicians.
Boolchand et al.
ANN INTERN MED 2006;145:654-659.
ABSTRACT
| FULL TEXT
Does a negative screening colonoscopy ever need to be repeated?
Brenner et al.
Gut 2006;55:1145-1150.
ABSTRACT
| FULL TEXT
Incomplete screening flexible sigmoidoscopy associated with female sex, age, and increased risk of colorectal cancer
Doria-Rose et al.
Gut 2005;54:1273-1278.
ABSTRACT
| FULL TEXT
Flexible Sigmoidoscopy in the PLCO Cancer Screening Trial: Results From the Baseline Screening Examination of a Randomized Trial
Weissfeld et al.
JNCI J Natl Cancer Inst 2005;97:989-997.
ABSTRACT
| FULL TEXT
Quality in the technical performance of screening flexible sigmoidoscopy: recommendations of an international multi-society task group
Levin et al.
Gut 2005;54:807-813.
ABSTRACT
| FULL TEXT
Colorectal Cancer Prevention
Hawk and Levin
JCO 2005;23:378-391.
ABSTRACT
| FULL TEXT
Fecal DNA versus Fecal Occult Blood for Colorectal-Cancer Screening in an Average-Risk Population
Imperiale et al.
NEJM 2004;351:2704-2714.
ABSTRACT
| FULL TEXT
JournalScan
Charnley et al.
Gut 2003;52:1653-1654.
FULL TEXT
Optimal Intervals and Techniques for Screening Sigmoidoscopy
Lev et al.
JAMA 2003;290:2122-2122.
FULL TEXT
Optimal Intervals and Techniques for Screening Sigmoidoscopy
Wender
JAMA 2003;290:2123-2123.
FULL TEXT
Optimal Intervals and Techniques for Screening Sigmoidoscopy
Sonnenberg and Lieberman
JAMA 2003;290:2122-2123.
FULL TEXT
Incidence of Advanced Adenomas and Distal Cancers After Negative Screening Sigmoidoscopy
JWatch Gastroenterology 2003;2003:1-1.
FULL TEXT
More frequent screening would improve detection of colon cancer
Gottlieb
BMJ 2003;327:70.
FULL TEXT
Screening Sigmoidoscopy-- How Often and How Good?
Fletcher
JAMA 2003;290:106-108.
FULL TEXT
|
